We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Video feature: Breaking through neonatal diabetes

27 July 2009

Testing blood
We spoke to Professors Andrew Hattersley and Frances Ashcroft about their research into diabetes, and met some people affected by the condition whose lives have been transformed as a result of this research.

Neonatal diabetes - a rare but severe form of the disease - used to mean a life of daily insulin injections and strict diet monitoring, often from birth. Now, however, many patients can take well-known drugs called sulphonylureas instead.

This transformation in their lives is due to the research of Professors Andrew Hattersley and Frances Ashcroft, who found that the condition was caused by a genetic mutation disrupting a critical potassium channel involved in the insulin secreting pathway and that sulphonylurea drugs could restore the channel's normal behaviour.

Sorry, but you need Flash Player 8 or higher to view the media player Download Flash


Running time: 5 min 16 s
Read the transcript [PDF 148KB]
View this video on YouTube
Take our video survey and you could win a £100 voucher.

Share |
Home  >  News and features  >  2009  > Breaking through neonatal diabetes
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888